Cite

HARVARD Citation

    Elsayed, H. et al. (2017). Rationally designed hecogenin thiosemicarbazone analogs as novel MEK inhibitors for the control of breast malignancies. Bioorganic & medicinal chemistry. 25 (24), pp. 6297-6312. [Online]. 
  
Back to record